David Gius, M.D., Ph.D., and colleagues are studying an aging-associated protein’s role in the development of breast cancer in older women. (Vanderbilt University/photo by Mary Donaldson)

Protein related to aging holds breast cancer clues

How cancer cells lose their (circadian) rhythm

Immortality and uncontrolled cell division are the fundamental differences between cancer cells and normal cells.

Southerners living in U.S. cancer belt; Vanderbilt-Ingram Cancer Center researchers study causes of malignancy

The South is known for many things: hot, steamy summers, iced tea laced with sugar and friendly people with a tendency to welcome strangers. But beneath the veneer of Southern hospitality and gracious living lurks a silent killer: cancer. Vanderbilt-Ingram Cancer Center researchers have their own name for the southern region of the United States: the "cancer belt."

President names Jennifer Pietenpol to National Cancer Advisory Board

President George W. Bush has appointed Jennifer A. Pietenpol, director of Vanderbilt-Ingram Cancer Center, to the National Cancer Advisory Board. Pietenpol, the B.F. Byrd Jr. Professor of Oncology at Vanderbilt-Ingram, will serve a six-year term through March 9, 2014.

Vanderbilt-Ingram Cancer Center named Blue Distinction Center for Complex and Rare CancersSM

Vanderbilt-Ingram Cancer Center has been selected as a Blue Distinction Center for Complex and Rare CancersSM by Blue Cross Blue Shield Association, in collaboration with BlueCross BlueShield of Tennessee.

Vanderbilt-Ingram Researchers Find Clue to Cancer Drug Allergies

Cancer patients from the Southeastern United States who are treated with the drug cetuximab, known commercially as Erbitux, are far more likely to suffer severe allergic reactions than patients in other regions of the country.

1 17 18 19 20 21 23